Stay updated on TACTIVE-U Study of ARV-471 Combo in Adv Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the TACTIVE-U Study of ARV-471 Combo in Adv Breast Cancer Clinical Trial page.

Latest updates to the TACTIVE-U Study of ARV-471 Combo in Adv Breast Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe web page has undergone significant changes, including the removal of detailed descriptions of a clinical trial for advanced or metastatic breast cancer, while adding new information about the study's registry identifier and collaborators. The revision number has also been updated.SummaryDifference20%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 11, 2025. However, the deletion of the date March 25, 2025, does not significantly impact the core content.SummaryDifference0.3%
- Check37 days agoChange DetectedThe page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3, replacing the previous date of February 11, 2025, and version 2.14.2.SummaryDifference0.2%
- Check73 days agoChange DetectedThe webpage has removed a notice regarding heavy traffic affecting NLM-NCBI services and a link to obtain contact information for a study center provided by Pfizer.SummaryDifference1%
- Check81 days agoChange DetectedThe webpage has updated its date information, removing several past dates and adding new future dates, indicating a shift in the timeline of events or availability.SummaryDifference0.8%
Stay in the know with updates to TACTIVE-U Study of ARV-471 Combo in Adv Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TACTIVE-U Study of ARV-471 Combo in Adv Breast Cancer Clinical Trial page.